Literature DB >> 27783579

Parkinson's disease: 4 big questions.

Sarah Deweerdt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27783579     DOI： 10.1038/538S17a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Movement disorders in 2016: Progress in Parkinson disease and other movement disorders.

Authors:  Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2017-01-13       Impact factor: 42.937

2.  Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease.

Authors:  Ludovica Iovino; Veronica Giusti; Francesca Pischedda; Elena Giusto; Nicoletta Plotegher; Antonella Marte; Ilaria Battisti; Angela Di Iacovo; Algerta Marku; Giovanni Piccoli; Rina Bandopadhyay; Carla Perego; Tiziana Bonifacino; Giambattista Bonanno; Cristina Roseti; Elena Bossi; Giorgio Arrigoni; Luigi Bubacco; Elisa Greggio; Sabine Hilfiker; Laura Civiero
Journal:  Acta Neuropathol       Date:  2022-05-21       Impact factor: 15.887

Review 3.  Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease.

Authors:  Dongping Huang; Jing Xu; Jinghui Wang; Jiabin Tong; Xiaochen Bai; Heng Li; Zishan Wang; Yulu Huang; Yufei Wu; Mei Yu; Fang Huang
Journal:  Parkinsons Dis       Date:  2017-07-31

Review 4.  The class II histone deacetylases as therapeutic targets for Parkinson's disease.

Authors:  Martina Mazzocchi; Louise M Collins; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neuronal Signal       Date:  2020-06-09

5.  Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila.

Authors:  Wei Liu; Kah-Leong Lim; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2022-10-17       Impact factor: 9.883

6.  LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.

Authors:  Marc Emmenegger; Elena De Cecco; Marian Hruska-Plochan; Timo Eninger; Matthias M Schneider; Melanie Barth; Elena Tantardini; Pierre de Rossi; Mehtap Bacioglu; Rebekah G Langston; Alice Kaganovich; Nora Bengoa-Vergniory; Andrès Gonzalez-Guerra; Merve Avar; Daniel Heinzer; Regina Reimann; Lisa M Häsler; Therese W Herling; Naunehal S Matharu; Natalie Landeck; Kelvin Luk; Ronald Melki; Philipp J Kahle; Simone Hornemann; Tuomas P J Knowles; Mark R Cookson; Magdalini Polymenidou; Mathias Jucker; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2021-07-26       Impact factor: 12.137
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.